Participants 121 149 4
acute promyelocytic leukemia
Participants 199 233 4
acute promyelocytic leukemia (APL)
Participants 703 883 6
previously untreated adult APL patients registered to protocol INT 0129 by the Eastern Cooperative Oncology Group, the Southwest Oncology Group, and the Cancer and Leukemia Group B
Participants 888 917 8
279 clinically eligible cases
Participants 919 949 8
230 were molecularly evaluable
Participants 2419 2431 4
APL patients
